human
util
cannabi
sativa
l
plant
millennia
medicin
recreat
purpos
c
sativa
l
plant
origin
central
asia
recent
seen
increas
interest
like
mani
applic
due
larg
phytochem
content
well
rich
sourc
cellulos
woodi
fiber
two
prepar
marijuana
recreat
use
hashish
resin
marijuana
leav
flower
synthet
cannabinoid
emerg
psychoact
substanc
recreat
use
recreat
use
marijuana
hashish
synthet
cannabinoid
associ
ischem
type
stroke
cannabinoid
oxygen
contain
aromat
hydrocarbon
compound
one
research
group
phytochem
c
sativa
l
includ
least
compound
thc
cannabidiol
cbd
wellknown
thc
synthet
cannabinoid
affin
cannabinoid
receptor
cbd
affin
cannabinoid
receptor
cannabinoid
receptor
anim
model
evid
show
modul
advers
effect
ischem
stroke
like
act
receptor
addit
cbd
laboratori
anim
model
shown
benefici
treatment
substanc
use
disord
includ
protect
liver
alcohol
damag
us
govern
recent
pass
agricultur
improv
act
includ
chang
product
market
hemp
deriv
cannabi
extrem
low
concentr
thc
chang
remov
hemp
control
substanc
act
preserv
us
food
drug
administr
fda
author
regul
cannabi
cannabisderiv
compound
studi
investig
toxicolog
proprietari
cbd
rich
hemp
extract
increas
interest
use
product
contain
cbd
human
essenti
fulli
evalu
safeti
cbd
consumpt
publish
oral
toxicolog
studi
cbd
hemp
extract
limit
current
avail
data
suggest
cbd
safe
human
consumpt
though
addit
studi
need
conduct
review
bergamaschi
et
al
describ
vivo
vitro
report
cbd
administr
varieti
dose
level
author
conclud
sever
studi
support
conclus
cbd
well
toler
safe
human
high
dose
chronic
use
evid
potenti
drug
metabol
interact
pharmacokinet
cytotox
decreas
receptor
activ
pharmacodynam
therefor
author
also
state
addit
studi
need
evalu
safeti
cbd
recent
review
conduct
iffland
grotenhermen
build
bergamaschi
et
al
review
regard
cbd
safeti
potenti
side
effect
review
also
conclud
numer
studi
show
cbd
well
toler
safe
human
high
dose
chronic
use
howev
order
understand
cbd
valid
find
addit
studi
evalu
safeti
cbd
need
object
current
studi
assess
genotox
preclin
safeti
proprietari
hemp
extract
contribut
signific
safeti
data
cbd
current
limit
avail
data
three
ame
test
one
extract
dilut
oliv
oil
two
undilut
extract
two
oral
gavag
dose
studi
rat
complet
preclin
studi
includ
rang
find
studi
studi
studi
recoveri
period
studi
studi
compliant
us
fda
good
laboratori
practic
preclin
studi
also
compliant
oecd
principl
good
laboratori
practic
us
fda
toxicolog
principl
safeti
assess
food
ingredi
redbook
revis
ivc
subchron
toxic
studi
rodent
oecd
guidelin
test
chemic
section
test
health
effect
repeat
dose
oral
toxic
studi
rodent
anim
hous
care
complianc
guid
care
use
laboratori
anim
current
state
scientif
knowledg
provid
accept
altern
use
live
anim
accomplish
object
studi
test
articl
studi
studi
mix
weight
volum
wv
oliv
oil
sigmaaldrich
st
loui
mo
oliv
co
norwalk
ct
obtain
desir
concentr
fresh
formul
contain
mgml
test
articl
oliv
oil
prepar
daili
formul
stir
ambient
temperatur
achiev
homogen
mixtur
studi
analyt
differ
neat
test
articl
collect
begin
dose
regimen
test
articl
collect
end
dose
regimen
ame
test
test
articl
use
anim
studi
test
well
undilut
extract
produc
use
two
differ
manufactur
method
isopropanol
extract
supercrit
extract
spraguedawley
male
femal
rat
charl
river
ig
stone
ridg
ny
raleigh
nc
use
studi
studi
rat
week
age
start
condit
interv
acclim
period
day
studi
day
studi
criteria
use
select
anim
studi
adequ
bodi
weight
gain
absenc
clinic
sign
diseas
injuri
bodi
weight
within
mean
within
sex
studi
rat
distribut
treatment
group
accord
stratif
bodi
weight
statist
signific
differ
among
group
bodi
weight
mean
within
sex
tabl
sixti
male
rat
weigh
g
femal
rat
weigh
g
distribut
treatment
group
stratifi
bodi
weight
among
dose
control
group
tabl
studi
bodi
weight
record
twice
acclim
period
weekli
durat
studi
feed
intak
determin
day
bodi
weight
determin
filter
potabl
water
feed
certifi
envigo
teklad
global
rodent
provid
ad
libitum
feed
water
assay
detriment
substanc
none
found
level
would
alter
studi
result
studi
sentinel
rat
kept
anim
room
serolog
done
sampl
collect
end
studi
sentinel
rat
neg
rat
parvoviru
toolan
viru
kilham
rat
viru
rat
minut
viru
parvoviru
rat
coronaviru
rat
theiloviru
pneumocysti
carinii
anim
studi
observ
daili
clinic
evid
ill
health
given
physic
exam
weekli
correspond
bodi
weight
determin
physic
exam
includ
observ
chang
skin
fur
eye
mucou
membran
occurr
secret
excret
autonom
activ
eg
lacrim
piloerect
pupil
size
unusu
respiratori
pattern
exam
also
includ
chang
gait
postur
respons
handl
well
presenc
clonic
tonic
movement
stereotypi
eg
excess
groom
repetit
circl
bizarr
behavior
eg
selfmutil
walk
backward
abnorm
observ
record
rat
studi
week
receiv
function
observ
batteri
open
field
excit
autonom
function
gait
sensorimotor
coordin
open
field
manipul
evalu
reactiv
sensit
elicit
behavior
abnorm
clinic
sign
includ
limit
convuls
tremor
unusu
bizarr
behavior
emaci
dehydr
gener
appear
addit
week
rat
studi
underw
motor
activ
assess
use
photobeam
activ
system
san
diego
instrument
inc
san
diego
ca
follow
recommend
procedur
investig
physic
examin
function
observ
batteri
motor
activ
assess
blind
treatment
rat
receiv
ophthalm
examin
done
rat
group
studi
veterinari
evalu
done
pretrial
period
studi
day
examin
done
use
focal
illumin
slit
lamp
biomicroscopi
indirect
ophthalmoscopi
studi
individu
dose
calcul
use
recent
weekli
bodi
weight
dose
adjust
oliv
oil
vehicl
rat
receiv
volum
mlkg
formul
test
substanc
administ
oral
approxim
time
hour
day
gavag
use
accept
procedur
treatment
nonrecoveri
rangefind
studi
mg
test
articlekg
bodi
weight
bw
day
day
tabl
control
group
receiv
mlkg
bw
oliv
oil
vehicl
studi
rat
dose
mg
test
articlekg
bwday
tabl
studi
rat
group
recoveri
period
sacrif
studi
male
rat
group
administ
test
articl
daili
day
femal
rat
group
administ
test
articl
daili
day
recoveri
period
day
femal
male
rat
respect
clinic
chemistri
paramet
given
tabl
studi
blood
overnight
fast
collect
necropsi
studi
day
inferior
vena
cava
rat
anesthet
isofluran
studi
blood
collect
group
hematolog
clinic
chemistri
studi
day
male
studi
day
femal
group
sacrific
studi
day
group
recoveri
sacrific
blood
sampl
hematolog
except
coagul
sampl
clinic
chemistri
collect
sublingu
bleed
rat
anesthet
isofluran
approxim
blood
collect
hematolog
paramet
precalibr
tube
contain
potassium
anticoagul
whole
blood
collect
tube
anticoagul
clinic
chemistri
paramet
tabl
whole
blood
sampl
kept
cold
examin
laboratori
use
standard
hematolog
method
clinic
chemistri
blood
allow
coagul
sampl
centrifug
refriger
centrifug
serum
supernat
harvest
place
cryotub
frozen
store
thaw
assay
hematolog
paramet
determin
advia
hematolog
system
siemen
erlangen
germani
clinic
chemistri
paramet
determin
coba
autoanalyz
roch
rotkreuz
switzerland
blood
sampl
use
determin
prothrombin
time
activ
partial
thromboplastin
time
collect
immedi
termin
sacrific
venipunctur
inferior
vena
cava
anesthesia
isofluran
approxim
ml
blood
collect
precalibr
tube
contain
anticoagul
sodium
citrat
sampl
centrifug
refriger
centrifug
plasma
transfer
label
tube
plasma
sampl
frozen
store
freezer
thaw
analyz
sysmex
siemen
erlangen
germani
day
collect
sampl
clinic
chemistri
evalu
anim
place
metabol
cage
food
withheld
least
hour
prior
blood
collect
void
urin
collect
anim
urin
sampl
refriger
analyz
tabl
urin
volum
measur
appear
record
chemic
paramet
measur
sg
reagent
strip
siemen
erlangen
germani
urin
sediment
evalu
light
microscopi
full
necropsi
done
studi
anim
includ
anim
remov
studi
includ
necropsi
examin
extern
bodi
surfac
bodi
orific
thorac
abdomin
cranial
caviti
inclus
content
surviv
anim
weigh
anesthet
isofluran
exsanguin
abdomin
aorta
gross
lesion
record
absolut
normal
organ
weight
organ
weightbodi
weight
determin
select
tissu
tabl
eye
epididymid
optic
nerv
test
fix
modifi
davidson
fix
store
ethanol
tissu
fix
neutral
buffer
formalin
specifi
tissu
embed
wax
thin
section
cut
stain
hematoxylin
eosin
examin
light
microscopi
histopatholog
tabl
studi
liver
adren
gland
treatment
control
anim
kidney
group
examin
histopatholog
studi
tissu
anim
remov
studi
tissu
group
liver
group
group
examin
histopatholog
chang
light
microscopi
tabl
gross
lesion
observ
describ
tissu
taken
examin
histopatholog
patholog
procedur
supervis
veterinari
mean
standard
deviat
calcul
quantit
data
inlif
endpoint
identifi
multipl
measur
continu
data
time
eg
bodi
weight
bodi
weight
gain
food
consumpt
food
effici
treatment
control
group
compar
use
twoway
analysi
varianc
anova
test
effect
time
treatment
method
account
repeat
measur
one
independ
variabl
signific
interact
observ
treatment
time
well
main
effect
analyz
post
hoc
multipl
comparison
test
eg
dunnett
test
individu
treat
group
control
warrant
suffici
group
size
endpoint
singl
measur
continu
data
within
group
eg
organ
weight
rel
organ
weight
evalu
homogen
varianc
normal
homogen
varianc
normal
distribut
observ
treat
control
group
compar
use
oneway
anova
oneway
anova
signific
comparison
treat
group
control
perform
multipl
comparison
test
eg
dunnett
test
varianc
consid
significantli
differ
group
compar
use
nonparametr
method
eg
kruskalw
nonparametr
analysi
varianc
nonparametr
analysi
varianc
signific
comparison
treat
group
control
perform
eg
dunn
test
signific
probabl
valu
p
hematolog
clinic
chemistri
data
male
femal
rat
analyz
separ
mean
standard
deviat
calcul
quantit
clinic
patholog
paramet
use
version
statist
analysi
xybion
corpor
lawrencevil
nj
data
analyz
sequenti
manner
first
bartlett
test
homogen
shapirowilk
test
normal
done
bartlett
test
homogen
shapirowilk
test
normal
signific
oneway
analysi
varianc
follow
dunnett
test
perform
bartlett
test
homogen
shapirowilk
test
normal
signific
data
transform
achiev
normal
varianc
homogen
done
order
transform
attempt
log
squar
root
rankord
log
squar
root
transform
fail
rankord
use
individu
observ
record
less
certain
valu
eg
lower
limit
quantit
calcul
perform
onehalf
record
valu
exampl
bilirubin
report
use
calcul
perform
bilirubin
data
individu
observ
record
greater
certain
valu
eg
upper
limit
quantit
greater
valu
use
place
record
valu
exampl
specif
graviti
report
use
calcul
perform
use
specif
graviti
valu
statist
test
signific
probabl
valu
p
mutagen
potenti
test
articl
well
undilut
extract
evalu
bacteri
revers
mutat
assay
accord
fda
glp
cfr
part
us
fda
redbook
ich
guidelin
four
strain
salmonella
typhimurium
one
strain
escherichia
coli
uvra
use
studi
conduct
presenc
absenc
metabol
activ
system
male
spraguedawley
rat
induc
phenobarbit
benzoflavon
moltox
inc
usa
overlay
agar
minim
glucos
agar
plate
purchas
moltox
inc
usa
fresh
bacteri
suspens
cultur
nutrient
broth
prepar
late
exponenti
phase
growth
use
test
articl
oliv
oil
formul
solut
dimethyl
sulfoxid
dmso
provid
requir
dose
level
account
activ
ingredi
cbd
undilut
extract
prepar
isopropanol
supercrit
extract
extract
formul
solut
dmso
provid
requir
dose
level
posit
control
use
presenc
absenc
metabol
activ
system
posit
control
substanc
includ
sodium
azid
icr
daunomycin
methyl
methanesulfon
typhimurium
strain
e
coli
uvra
respect
absenc
metabol
activ
strain
presenc
metabol
activ
initi
test
test
articl
util
plate
incorpor
method
follow
materi
mix
pour
onto
minim
agar
plate
prepar
test
substanc
solutionsneg
controlposit
control
substanc
mix
substat
buffer
bacteri
suspens
overlay
agar
plate
incub
growth
adequ
enumer
confirmatori
test
test
articl
conduct
util
preincub
method
test
control
substanc
bacteri
suspens
mix
substitut
buffer
incub
agit
approxim
minut
prior
mix
overlay
agar
pour
onto
minim
agar
plate
proceed
initi
test
strain
use
dose
level
initi
test
test
articl
plate
test
prepar
triplic
experiment
point
final
dose
util
extract
dilut
oliv
oil
undilut
isopropanol
extract
final
dose
util
initi
confirmatori
test
undilut
supercrit
extract
final
dose
util
initi
test
confirmatori
test
due
toxic
note
strain
supercrit
extract
supplement
test
conduct
ensur
five
concentr
could
assess
without
toxic
plate
incorpor
preincub
method
use
previous
describ
final
dose
follow
incub
number
coloni
per
plate
count
manual
andor
aid
plate
counter
mean
standard
deviat
calcul
set
triplic
plate
test
consid
valid
control
plate
normal
background
lawn
mean
revert
coloni
count
strain
treat
vehicl
close
within
expect
laboratori
histor
control
rang
publish
valu
posit
control
produc
substanti
increas
revert
coloni
number
appropri
bacteri
strain
plate
also
evalu
cytotox
indic
partial
complet
absenc
background
lawn
nonrevert
bacteria
substanti
doserel
reduct
revert
bacteria
studi
concentr
verif
analysi
day
averag
mgml
target
concentr
mgml
group
respect
studi
concentr
complianc
rang
day
sampl
averag
day
sampl
averag
day
sampl
averag
target
concentr
mgml
respect
mortal
studi
link
administr
test
articl
oliv
oil
vehicl
studi
nonstatist
signific
p
decreas
bodi
weight
male
femal
rat
group
femal
rat
studi
test
articlerel
chang
p
mean
weekli
bodi
weight
daili
bodi
weight
gain
food
consumpt
food
effici
male
rat
group
statist
signific
p
dosedepend
decreas
mean
weekli
bodi
weight
observ
correl
signific
decreas
p
mean
daili
bodi
weight
gain
food
effici
group
well
food
consumpt
group
end
recoveri
period
dosedepend
decreas
mean
weekli
bodi
weight
still
observ
male
rat
group
correl
signific
decreas
p
mean
daili
bodi
weight
gain
food
consumpt
group
well
food
effici
male
rat
group
group
anim
studi
clinic
sign
consist
hypoact
hyperact
reduc
food
consumpt
piloerect
directli
attribut
test
articl
administr
studi
advers
clinic
observ
consist
across
treatment
group
observ
link
patholog
observ
treatment
group
studi
consist
abnorm
find
ophthalmolog
function
observ
batteri
motor
activ
assess
examin
treatmentlink
chang
hematolog
clinic
chemistri
valu
group
male
femal
rat
studi
increas
blood
urea
nitrogen
serum
creatinin
studi
signific
chang
p
group
hematolog
prothrombin
activ
partial
thromboplastin
time
urinalysi
clinic
chemistri
tabl
tabl
macroscop
lesion
observ
studi
link
administr
test
articl
boardcertifi
veterinari
pathologist
dacvp
evalu
tissu
histopatholog
studi
centrilobular
hepatocellular
hypertrophi
increas
cell
size
group
seen
correl
increas
liver
weight
adren
cortic
vacuol
observ
mild
group
anim
minim
mild
group
male
group
femal
minim
group
male
studi
test
articl
relat
histopatholog
chang
limit
hepatocellular
hypertrophi
centrilobular
hepatocyt
lesion
seen
male
femal
anim
group
hepatocellular
hypertrophi
associ
dosedepend
increas
absolut
liver
weight
group
femal
livertobodi
weight
ratio
group
femal
livertobodybrain
weight
ratio
group
femal
signific
p
increas
livertobodi
weight
ratio
group
femal
livertobodybrain
weight
ratio
group
femal
seen
increas
liver
weight
ratio
correl
microscop
find
hepatocellular
hypertrophi
dose
level
nonsignific
p
dosedepend
increas
absolut
liver
weight
observ
group
femal
centrilobular
hepatocellular
hypertrophi
increas
liver
weight
seen
recoveri
group
end
recoveri
period
indic
hepatocellular
hypertrophi
revers
vacuol
zona
fasciculata
incid
sever
observ
adren
gland
treatment
control
group
male
rat
correl
increas
weight
adren
gland
addit
statist
signific
increas
p
adrenaltobodi
weight
ratio
observ
group
femal
correl
adren
histopatholog
concentr
relat
substanti
test
articl
relat
increas
number
revert
coloni
strain
test
presenc
absenc
metabol
activ
mix
either
plate
incorpor
preincub
method
data
shown
precipit
interf
lawn
evalu
note
strain
dose
obscur
count
test
dilut
test
articl
precipit
obscur
lawn
evalu
seen
strain
supercrit
extract
dose
without
plate
incorpor
preincub
method
toxic
evid
strain
ta
ta
ta
e
coli
uvra
without
plate
incorpor
andor
preincub
test
precipit
obscur
lawn
evalu
seen
strain
isopropanol
extract
dose
without
plate
incorpor
preincub
method
toxic
note
strain
ta
ta
andor
without
preincub
method
studi
consid
valid
mean
revert
coloni
count
vehicl
control
close
within
expect
rang
base
laboratori
histor
control
andor
publish
valu
posit
control
substanc
result
expect
substanti
increas
revert
coloni
count
mutagen
test
show
extract
dilut
oliv
oil
well
extract
produc
isopropanol
supercrit
extract
method
mutagen
bacteria
ame
assay
recent
increas
interest
regard
health
benefit
cbd
phytocannabinoid
increas
interest
research
also
conduct
assess
safeti
compound
human
consumpt
current
studi
perform
better
understand
toxicolog
profil
cbd
rich
proprietari
hemp
extract
assess
result
tandem
inform
current
avail
regard
toxic
safeti
cbd
marx
et
al
report
batteri
glp
compliant
toxicolog
studi
conduct
supercrit
extract
aerial
part
c
sativa
plant
assay
extract
edibl
fatti
acid
phytocannabinoid
approxim
cbd
thc
plant
chemic
includ
fatti
alkan
plant
sterol
triterpen
tocopherol
repeat
oral
doserang
find
studi
report
marx
et
al
observ
advers
effect
level
noael
could
determin
howev
result
repeat
dose
studi
recoveri
period
wistar
rat
also
report
studi
dose
sunflow
oil
vehicl
mg
extractkg
bw
per
day
use
signific
decreas
bodi
weight
bodi
weight
gain
differ
variou
organ
weight
compar
control
report
mid
high
dose
level
author
conclud
mani
find
revers
trend
toward
normal
end
recoveri
period
noael
hemp
extract
wistar
rat
studi
determin
mg
kg
bw
per
day
mgkg
bw
per
day
male
femal
respect
studi
report
test
articl
relat
signific
chang
bodi
weight
daili
bodi
weight
gain
feed
effici
seen
male
treatment
group
still
note
end
recoveri
period
magnitud
signific
chang
bodi
weight
daili
bodi
weight
gain
feed
effici
low
mid
dose
group
less
show
sign
obviou
recoveri
therefor
consid
toxicolog
relev
effect
male
receiv
mgkgday
still
evid
end
recoveri
period
consid
toxicolog
relev
report
rodent
studi
differ
find
hepatotox
cbd
oral
administ
high
dose
hepatocellular
hypertrophi
centrilobular
pattern
observ
rat
liver
studi
report
pattern
hepatocellular
hyperplasia
frequent
observ
rat
anim
expos
agent
induc
cyp
famili
enzym
associ
activ
peroxisom
proliferatoractiv
receptor
ppar
thc
affin
cbd
low
affin
high
affin
interact
one
mechan
action
cbd
studi
show
mechan
action
hepatocellular
hypertrophi
show
activ
liver
enzym
serum
significantli
chang
treatment
test
articl
hepatocellular
hypertrophi
revers
recoveri
period
studi
report
marx
et
al
histopatholog
chang
observ
liver
treat
control
rat
liver
weight
male
femal
rat
mgkg
bodi
weightday
significantli
increas
p
day
recoveri
male
femal
receiv
mgkgday
retain
significantli
increas
hepat
weight
induct
hepat
drug
metabol
enzym
hdme
associ
increas
liver
weight
hepatocellular
hypertrophi
hyperplasia
increas
number
cell
elev
hepaticsourc
enzym
serum
evid
scientif
literatur
support
conclus
centrilobular
pattern
hepatocellular
hypertrophi
increas
liver
weight
observ
studi
due
induct
hdme
andor
peroxisom
hepatocellular
necrosi
chang
clinic
chemistri
occur
evid
liver
damag
occur
conclus
support
observ
hepatocellular
hypertrophi
increas
liver
weight
recoveri
group
receiv
test
articl
studi
laboratori
anim
shown
cbd
protect
liver
toxic
insult
studi
report
treat
control
male
rat
incid
sever
vacuol
adren
zona
fasciculata
adren
weight
significantli
increas
group
femal
vacuol
adren
zona
fasciculata
increas
adren
weight
observ
group
histopatholog
lesion
note
adren
gland
current
studi
seen
control
high
dose
male
consid
due
treatment
test
articl
toxicolog
relev
hemp
extract
studi
shown
nonmutagen
bacteri
test
system
use
evalu
mutagen
marx
et
al
report
glpcompliant
studi
concentr
supercrit
extract
c
sativa
mutagen
bacteri
test
system
glpcompliant
mutagen
test
dilut
extract
show
concentr
mutagen
without
metabol
activ
extract
produc
isopropanol
extract
supercrit
extract
mutagen
without
metabol
activ
concentr
bacteri
test
system
mix
caus
mutagen
provid
evid
mutagen
metabolit
produc
extract
two
addit
ame
test
conduct
undilut
extract
produc
two
differ
extract
method
conduct
determin
method
product
oliv
oil
diluent
impact
result
ame
assay
mutagen
note
test
conduct
botan
extract
evalu
mutagen
mutagen
studi
extract
plant
euphorbia
triaculeata
show
mutagen
provid
protect
mutagen
effect
cyclophosphamid
studi
novel
tast
modul
powder
deriv
cordycep
sinensi
show
product
mutagen
ame
test
result
support
micronucleu
assay
studi
genotox
cbd
cell
cbd
significantli
caus
dna
damag
hour
incub
cbd
also
shown
comet
assay
protect
cell
hydrogen
peroxideinduc
dna
damag
cbd
oral
dose
mgkg
shown
significantli
p
reduc
azoxymethaneinduc
colon
aberr
crypt
foci
colon
polyp
tumor
summari
test
articl
undilut
dilut
oliv
oil
mutagen
bacteri
revers
mutat
assay
noael
studi
conclud
mgkg
bwday
mgkg
bwday
femal
male
spragu
dawley
rat
respect
assess
add
signific
data
current
avail
literatur
safeti
toxicolog
cbd
rich
hemp
extract
given
potenti
cbd
varieti
human
use
limit
data
current
avail
result
support
hemp
extract
like
safe
human
consumpt
addit
studi
conduct
valid
conclus
author
declar
conflict
interest
except
margitta
dziwenka
conceptu
write
origin
draft
write
review
edit
robert
coppock
write
origin
draft
write
review
edit
alexand
mccorkl
eddi
palumbo
carlo
ramirez
stephen
lermer
